Alendronate Compared to Metformin in Chronic Periodontitis

NCT02461667 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2015-06-03

No results posted yet for this study

Summary

This is a 9 month randomised controlled clinical comparing the clinical efficacy of 1%metformin and 1%alendronate in chronic periodontitis subjects.

Conditions

  • Chronic Periodontitis

Interventions

DRUG

SRP plus Placebo Gel

After SRP, placebo gel was delivered subgingivally into the pocket

DRUG

SRP plus Alendronate gel

Alendronate (ALN) After SRP, ALN gel was delivered subgingivally into the pocket

DRUG

SRP plus Metformin gel

Metformin (MF) After SRP, MF gel was delivered subgingivally into the pocket

Sponsors & Collaborators

  • Government Dental College and Research Institute, Bangalore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-03-31
Completion
2015-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02461667 on ClinicalTrials.gov